MOUNTAIN VIEW, Calif. - Alto Neuroscience, Inc. (NYSE: ANRO), currently trading at $3.11 and down nearly 26% over the past week, has announced the continuation of its Phase 2b clinical trial for ...

While there are many treatment options for depression, natural remedies, self-care methods, and alternative therapies can ...

Millions of Americans suffer from winter-pattern seasonal affective disorder, or SAD. Shorter, darker days and cold nights ...